In the context of one dose could work, that's different from saying it would work.
We do have preliminary evidence to say that there is high efficacy following one dose, but we need more data to understand the durability of that effectiveness and whether or not it wanes. So that's why the discussion around the dose interval remains very alive in the scientific community, and that's why NACI will be looking at that again next week at their meeting.